Evidence map›Paper›PMID 41917514›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Stimulus-responsive molecular imaging propels stem cell research: from passive localization to active event recognition.

Feiyi Chu, Bin Feng, Yan Zhong, Taolan Zhang, Wenbin Zeng, Mei Tian, Hong Zhang

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Feiyi ChuXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, PR China.
Bin FengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, PR China.
Yan ZhongDepartment of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, PR China.
Taolan ZhangDepartment of Pharmacy, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, PR China.
Wenbin ZengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410078, PR China. wbzeng@hotmail.com.
Mei TianHuashan Hospital & Human Phenome Institute, Fudan University, Shanghai, 201203, PR China. tianmei@fudan.edu.cn.
Hong ZhangDepartment of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, PR China. hzhang21@zju.edu.cn.ORCID http://orcid.org/0000-0002-4084-5150

Funding

Key Technologies Research and Development Program 2021YFA1101700National Natural Science Foundation of China 82030049National Natural Science Foundation of China 82572300
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41917514

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.